The Application Portal for the ATS 2024 BEAR Cage Competition has closed. Please see below for this year’s finalists.
We invite you to join us for the live competition in San Diego, CA.
The BEAR Cage (Building Education to Advance Research) Competition is hosted annually by the Drug, Device, Discovery, and Development (DDDD) Committee. The program is open to early-stage investigators with highly innovative, translational, human-focused research proposals. The top three submissions are chosen by the DDDD Committee and the finalists are invited to pitch their proposals to a panel of translational science experts representing academia, industry, and governmental sectors in front of a live audience at the ATS International Conference.
The panel, with audience participation, will “vet” these proposals with each presenter, providing a unique “shark-tank” like learning environment that fuels real-time feedback and propels the strategic thinking required for these novel ideas to become innovations. After each presentation, the live panel and audience will have sufficient time to ask questions to each of the top three contestants. Ultimately, the panel will award one grand prize winner a $10,000 prize and the two runner-up proposals $2,500 each.
For any questions about the application process or the competition for ATS 2024, please send an email to dddd@thoracic.org.
ATS 2024 BEAR Cage Competition
Mark your calendars for May 20, 2024, from 1:30 - 3:30 p.m. and cheer on our three finalists with the following research presentations:
Eno-Obong Essien, MD
Department of Medicine, Division of Pulmonary and Critical Care Medicine- Massachusetts General Hospital
“Endothelial-Targeted mRNA-Lipid Nanoparticles; A Novel Therapeutic for Treating Acute Respiratory Distress Syndrome "
Julio Huapaya, MD, MHS S
Critical Care Fellow, National Institutes of Health
“Integrating Myositis-Specific Autoantibody Quantification Using a Novel Assay and High-Density Proteomics for Precision Management of Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease”
Michael Milled, MD
Pulmonary and Critical Care Fellowship - University of California San Diego
“A Novel Intracorporeal Oxygenation Device for Patients with Severe Acute Lung Injury”
